This was supposed to be an easy year for M&A in France. A business-friendly government, the prospect of a Brexit-related influx of investment and the availability of plentiful financing at low interest rates all promised to keep the deal pipeline full and M&A teams busy at firms of all sizes.
That was before COVID-19 took easy off the table and replaced it with complicated and unpredictable. The battle in France against the novel coronavirus pandemic entered a critical phase this month that is expected to last eight to 12 weeks, at least. A nationwide lockdown that started March 17 is likely to be extended beyond its initial 15 days.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
